155 related articles for article (PubMed ID: 24835804)
21. Subtypes of stage IV ovarian cancer; response to treatment and patterns of disease recurrence.
Jamieson A; Sykes P; Eva L; Bergzoll C; Simcock B
Gynecol Oncol; 2017 Aug; 146(2):273-278. PubMed ID: 28549816
[TBL] [Abstract][Full Text] [Related]
22. The role and prognostic value of inducible nitric oxide synthase (iNOS) and interleukin-33 (IL-33) in serous and mucinous epithelial ovarian tumours.
Saied EM; El-Etreby NM
Ann Diagn Pathol; 2017 Apr; 27():62-68. PubMed ID: 28325363
[TBL] [Abstract][Full Text] [Related]
23. [Clinicopathologic analysis of 130 cases of mucinous borderline ovarian tumors].
Cao DY; Shen K; Tao T; Yang JX; Xiang Y; Huang HF; Wu M; Pan LY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):15-8. PubMed ID: 21429428
[TBL] [Abstract][Full Text] [Related]
24. Epithelial ovarian cancer.
Ng JS; Low JJ; Ilancheran A
Best Pract Res Clin Obstet Gynaecol; 2012 Jun; 26(3):337-45. PubMed ID: 22281513
[TBL] [Abstract][Full Text] [Related]
25. Borderline ovarian tumors" A contemporary review of clinicopathological characteristics, diagnostic methods and therapeutic options.
Solmaz Hasdemir P; Guvena T
J BUON; 2016; 21(4):780-786. PubMed ID: 27685896
[TBL] [Abstract][Full Text] [Related]
26. Co-Existing Ovarian Mucinous Cystadenocarcinoma with Mature Cystic Teratoma: A Rare Case Report.
Suwannarurk K; Thaweekul Y; Mairaing K; Poomtavorn Y; Piyawong W; Himakhun W; Bhamarapravatana K
J Med Assoc Thai; 2016 Jul; 99 Suppl 4():S281-6. PubMed ID: 29927186
[TBL] [Abstract][Full Text] [Related]
27. Recurrent intestinal mucinous borderline tumors of the ovary: a report of 5 cases causing problems in diagnosis, including distinction from mucinous carcinoma.
Irving JA; Clement PB
Int J Gynecol Pathol; 2014 Mar; 33(2):156-65. PubMed ID: 24487471
[TBL] [Abstract][Full Text] [Related]
28. Rupture of a malignant ovarian tumor in pregnancy presenting as acute abdomen.
Malhotra N; Sumana G; Singh A; Deka D; Mittal S
Arch Gynecol Obstet; 2010 May; 281(5):959-61. PubMed ID: 19949808
[TBL] [Abstract][Full Text] [Related]
29. All-Cause Mortality After Fertility-Sparing Surgery for Stage I Epithelial Ovarian Cancer.
Melamed A; Rizzo AE; Nitecki R; Gockley AA; Bregar AJ; Schorge JO; Del Carmen MG; Rauh-Hain JA
Obstet Gynecol; 2017 Jul; 130(1):71-79. PubMed ID: 28594773
[TBL] [Abstract][Full Text] [Related]
30. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
[TBL] [Abstract][Full Text] [Related]
31. Ovarian cancer patients with localized relapse: clinical outcome and prognostic factors.
Petrillo M; Fagotti A; Ferrandina G; Fanfani F; Costantini B; Vizzielli G; Pedone Anchora L; Nero C; Margariti PA; Scambia G
Gynecol Oncol; 2013 Oct; 131(1):36-41. PubMed ID: 23791829
[TBL] [Abstract][Full Text] [Related]
32. Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm.
Taylor J; McCluggage WG
Am J Surg Pathol; 2015 Jul; 39(7):983-92. PubMed ID: 25723110
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of conservative surgery in early epithelial ovarian carcinoma.
Cheng X; Cheng B; Wan X; Lu W; Xie X
Eur J Gynaecol Oncol; 2012; 33(1):93-5. PubMed ID: 22439414
[TBL] [Abstract][Full Text] [Related]
34. Is lymphadenectomy necessary in mucinous ovarian cancer? A single institution experience.
Salgado-Ceballos I; Ríos J; Pérez-Montiel D; Gallardo L; Barquet-Muñoz S; Salcedo-Hernández R; Pérez-Plasencia C; Herrera LA; Cantú de León DF
Int J Surg; 2017 May; 41():1-5. PubMed ID: 28315410
[TBL] [Abstract][Full Text] [Related]
35. Association of mucinous tumors of the ovary and appendix. A clinicopathologic study of 25 cases.
Seidman JD; Elsayed AM; Sobin LH; Tavassoli FA
Am J Surg Pathol; 1993 Jan; 17(1):22-34. PubMed ID: 8383467
[TBL] [Abstract][Full Text] [Related]
36. Survival impact of capsule status in stage I ovarian mucinous carcinoma-A mulicentric retrospective study.
Kajiyama H; Suzuki S; Yoshikawa N; Kawai M; Nagasaka T; Kikkawa F
Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():131-136. PubMed ID: 30685661
[TBL] [Abstract][Full Text] [Related]
37. Optical biomarkers of serous and mucinous human ovarian tumor assessed with nonlinear optics microscopies.
Adur J; Pelegati VB; de Thomaz AA; Baratti MO; Almeida DB; Andrade LA; Bottcher-Luiz F; Carvalho HF; Cesar CL
PLoS One; 2012; 7(10):e47007. PubMed ID: 23056557
[TBL] [Abstract][Full Text] [Related]
38. Ovarian cancer risk factors by tumor dominance, a surrogate for cell of origin.
Kotsopoulos J; Terry KL; Poole EM; Rosner B; Murphy MA; Hecht JL; Crum CP; Missmer SA; Cramer DW; Tworoger SS
Int J Cancer; 2013 Aug; 133(3):730-9. PubMed ID: 23364849
[TBL] [Abstract][Full Text] [Related]
39. [Expressions of osteopontin and B7-H4 in epithelial ovarian neoplasm and their significance].
Zhang LL; Shao SL; Wu Y
Chin J Cancer; 2010 Jan; 29(1):25-9. PubMed ID: 20038306
[TBL] [Abstract][Full Text] [Related]
40. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
